Stromally expressed c-Jun regulates proliferation of prostate epithelial cells Publication: Bill Li, W., C. L. Wu, P. G. Febbo, and A. F. Olumi. 2007. Stromally Expressed C-Jun Regulates Proliferation of Prostate Epithelial Cells.
MR imaging of renal masses: correlation with findings at surgery and pathologic analysis Publication: Bill Pedrosa, I., M. R. Sun, M. Spencer, E. M. Genega, A. F. Olumi, W. C. Dewolf, and N. M. Rofsky. 2008. MR Imaging of Renal Masses: Correlation With Findings at Surgery and Pathologic Analysis.
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system Publication: Bill Dong, F., C. Wang, A. B. Farris, S. Wu, H. Lee, A. F. Olumi, W. S. McDougal, R. H. Young, and C. L. Wu. 2012. Impact on the Clinical Outcome of Prostate Cancer by the 2005 International Society of Urological Pathology Modified Gleason Grading System.
5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer Publication: Bill Preston, M. A., K. M. Wilson, S. C. Markt, R. Ge, C. Morash, M. J. Stampfer, M. Loda, E. Giovannucci, L. A. Mucci, and A. F. Olumi. 2014. 5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.
Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity Publication: Bill Yun, H., J. Xie, A. F. Olumi, R. Ghosh, and A. P. Kumar. 2015. Activation of AKR1C1/ERβ Induces Apoptosis by Downregulation of C-FLIP in Prostate Cancer Cells: A Prospective Therapeutic Opportunity.
Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer Publication: Bill Frendl, D. M., and A. F. Olumi. 2017. Understanding Temporal Trends in Medical Costs Associated With Progression to Metastatic Prostate Cancer.
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience Publication: Bill Rodin, D., M. Drumm, R. Clayman, D. L. Buscariollo, S. Galland-Girodet, A. Eidelman, A. S. Feldman, et al. 2017. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-Term Results of a Single-Institution Experience.
Metformin inhibits the proliferation of benign prostatic epithelial cells Publication: Bill Wang, Z., X. Xiao, R. Ge, J. Li, C. W. Johnson, C. Rassoulian, and A. F. Olumi. 2017. Metformin Inhibits the Proliferation of Benign Prostatic Epithelial Cells.
Would You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center Publication: Bill Burns, R. B., A. F. Olumi, D. K. Owens, and G. W. Smetana. 2019. Would You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy Publication: Bill Wang, Z., T. Deng, X. Long, X. Lin, S. Wu, H. Wang, R. Ge, et al. 2020. Methylation of SRD5A2 Promoter Predicts a Better Outcome for Castration-Resistant Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.